on monoamine-opioid peptide interaction in rat central nervous system. BRAIN RES. BULL.9(1-6) 1982.-Light microscopic imm~ocy~ch~m~st~ was employed to investigate possible sites of interaction between the endogenous opioid peptides and monoamines in the rat central nervous system. The opioid and related peptides examined included beta-endorphin @-END), alpha-MSH (a-MSH) and bucineenkephahn (Leu-ENK). The monoamines were examined using antisera generated against tyrosine hydroxylase, dopamine-P-hydroxylase as well as serotonin. Due to the long-tract nature of the central monoamine prajections as well as P-END/a-MSH fiber systems, serial section analyses were performed utilizing parasagittal brain sections. Many areas rich in both the monoamines as well as opioid peptides were investigated. These included several thahunic and hypothalamic nuclei, several limbic structures, mesencephabc periaqueductal gray, brain stem noradrenergic cell groups and their rostral projections, the dopaminergic nigrostriati system, and the serotonergic raphe nuclei and their projections. The results suggest a more intimate linkage between the monoamines and the opioid peptides than previous& reahzed. Some of the intricacies of monoamine-opioid peptide interaction, in particular those pertaining to their possible roie in pain and analgesia, catalepsy, and neuroendocrine effects are also discussed.
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Limbic system Perigqueductal gray EVER since the discovery of endogenous opioid peptides and their subsequent localization in specific central nervous system loci, it has become increasingly apparent that there exists a potential for an intimate interaction between these peptides and the mono~inergic systems. In fact, many investigators have noted the possibility of such an interaction while studying the distributional patterns of the opioid peptides (cf.
[ ISI]), In this chapter, we shah present data from our recent immunocytochemical studies suggesting a much more intimate linkage between the opioid peptides and monoamines than previously realized. Additionally, we will analyze some of the more sahent features of mo~oamine-opioid peptide interaction in the rat centrat nervous system. Heavier emphasis will be placed upon the anatomical aspects of these interactions, along with the discussion of possible physiological implications where such is applicable. This article then is not an exhaustive review of the literature, rather a specialized, and we hope useful treatise of this subject. For those who have fur&r interests in the topic, there will be references made to some of the more thorough reviews of the literature.
ENDOGENOUS OPIOID SYSTEMS
It is now clear that there exists within the central nervous system three distinct opioid peptidergic systems, namely those containing methionine-and Ieucine-enkephalin (metand leu-ENK), beta-endorphin (P-END), and dynorphin (DYN) (and possibly cy-and @-neo-endorphin). The opioid peptides demonstrate a high affinity for opiate receptors, and can induce narcotic agonist effects much like those produced by morphine administration.
These effects have been demonstrated for met-and leu-ENK [23,55,56,69, 106, 1361 for P-END [lQ, 22, 74, 75, 83, 84, 138, 139, 1541 , and for DYN [41] . Furthermore, immunocytochemical studies have revealed a separate and distinct distributional pattern for each of the opioid peptides.
Ergkephalins
The enkephalins were discovered in the mammalian brain by Hughes et al. [56] , and were shown to exist in entirely separate neuronal systems from that containing P-END and its related peptides [16,1491. Met-and leu-ENK containing perikarya and f%ers have a wide distribution throughout the neuraxis, and can be found in certain fimbic structures, neostriatum, hypothalamus, periventricuhu and periaqueductal gray areas, locus coeruleus, as well as many lower brain stem structures and the spinal cord [32,48,X), 60, 125, 131, 141, 142, 147, 1551 . Although these two peptides appear to ' This work was supported by NIDA grant 02265 (S. J. Watson), NSF grant BNSgo04512 (S. J. Watson) 108] . It has also been shown to exist in the brain in neuronal perikarya located in the arcuate and peri-arcuate regions of the hypothalamus. Fibers from this single system which also stores ACTH and a-MSH, project to hypothalamus, several limbic areas, periventricular thalamus, periaqueductal gray, the locus coeruleus, and medullary reticular formation [S, 6, 14, 16, 17, 148, 149, 150, 1621 . Recently, other P-END containing neuronal perikarya have been localized in the brain stem of colchicine pre-treated rats, in the vicinity of the A2 noradrenergic cell group [ 1281 and within nucleus reticularis gigantocellularis and motor trigeminal nucleus [36] . However, it remains to be seen whether or not these cells contain "true" P-END.
Dynorphin
Lastly, DYN, discovered by Goldstein et al. [41] appears to contain the leu-ENK molecule as its N-terminus, just as P-END contains met-ENK at its N-terminus. However, the COOH-terminus of DYN is unique to that peptide only. This peptide has been found to exist in the same hypothalamic magnocellular neurons that produce vasopressin in both the supraoptic and paraventricular nuclei. It has also been localized to medullary and spinal cord neurons [ 152. 1531.
MONOAMINERGIC SYSTEMS

Norepinephrine (NE)
Noradrenergic systems arise from several brain stem loci and have extensive and widespread projections throughout the neuraxis [26, 77, 1431 . The nucleus locus coeruleus is the largest NE producing nucleus and is the primary source of central noradrenergic innervation, giving rise to fibers that course through the dorsal NE bundle in the midbrain periaqueductal gray to higher structures [7, 77, 811. Other NE-producing cell groups collectively known as the lateral tegmental noradrenergic system, give rise to both descending and ascending (ventral NE-bundle) projections. NE terminals can be found in the spinal cord, brain stem, thalamus and hypothalamus, as well as many limbic and other telencephalic structures.
Dopamine (DA)
The dopaminergic cell groups of the mesencephalon [26], the most prominent of which is located in the substantia nigra give rise to ascending projections to the neostriatum (Caudate-putamen) via the nigrostriatal pathway, as well as other limbic and forebrain structures via the mesolimbic and mesocortical DA pathways which project to the nucleus accumbens, lateral septum and several cortical areas 177, 79, 80, 1431. Additionally the tuberoinfundibular DA neurons in the arcuate-periventricular region and the incertohypothalamic DA neurons in the zona incerta seem to exert their action upon the endocrine hypothalamus [ 13,491.
Serotonin (5HT)
5HT neuronal systems originate from the nuclei of the raphe which are midline structures in the regions of the mesencephalon, pons, and medulla [26] . Two of the most prominent 5HT nuclei are the raphe dorsalis and raphe magnus. These and other raphe neurons give rise to several pathways which include: ventral and dorsal ascending as well as other descending pathways to the spinal cord [ [143] , and Lindvall and Bjorklund [78] . No monoamine cell bodies are shown. Superimposed upon the monoaminergic systems are the projections of P-END/a-MSH fibers (dashes) which originate from cell bodies in the hypothalamic arcuate nucleus. Also shown are /3-END/WMSH cell bodies in the intermediate and anterior lobes of the pituitary. Note the close association between the projections of these systems. The projections of the a-2 ((r-MSH) system to the cortex and hippocampus are not shown. The reader is cautioned that due to the wealth of data, this schematic drawing is necessarily oversimplified. Also, many monoamine nuclei were omitted. Abbreviations: Al, A2, (noradrenergic cell groups).
AC (anterior commissure). ACB (nucleus accumbens). AL (anterior lobe of pituitary). ARN (arcuate nucleus). CC (corpus callosum). CPU (caudate-putamen). DCA (dorsal catecholamine bundle). HPC (hippocampus). IC (inferior colliculus). IL (intermediate lobe of pituitary). LC (locus coeruleus). ME (median eminence). MFB (medial forebrain bundle). NL (neural lobe of pituitary). NTS (nucleus tractus solitarius). OB (olfactory bulb). OT (optic tract). P (pons). PAG (periaqueductal gray). PV (periventricular thalamus). RD (raphe dorsalis). RM (raphe magnus). SC (superior colliculus). SN (substantia nigra). SPT (septum). V (ventricle). VCA (ventral catecholamine bundle).
River) were used in this study. The immunocytochemical technique used here is described elsewhere [148, 149] . Briefly, each animal is anesthetized by an intraperitoneal injection of sodium pentobarbital.
The animal is then immersed in ice-water and the chest cavity is opened. The right atrium is cut open and the cardiovascular system is flushed with 50 ml cold saline administered through the left ventricle. The ventricles are cut away and a perfusion tube is inserted into the aorta and tied in place. The animal is perfused with 4% buffered formaldehyde at 4°C for 30 minutes. The brain is then excised, blocked and placed in the perfusion mixture for one hour at 4°C. Next, the blocks are transferred into 15% sucrose in phosphate buffered saline (PBS) and stored overnight at 4°C. The following day, the blocks are immersed in Tissue Tek (O.C.T.) and are frozen by immersion into liquid nitrogen. For sectioning, the O.C.T. blocks are frozen onto brass cryostat chucks and sectioned at -20°C. In this study, the brains were sectioned at the sagittal plane. The sections are picked up onto gelatin-coated slides and are stored at -90°C until further processing.
For immunocytochemistry, the sections are air-dried and placed in an incubator, set at 37°C. Primary rabbit antisera against particular antigens (see Table 1 ) are diluted with 0.3% T&on-PBS and applied to the sections and allowed to incubate for one hour. These are then incubated overnight at 4°C.
The following day, the slides are washed in PBS and then incubated with goat anti-rabbit immunoglobulin (GAR-IgG) for 1 hour at 37°C and then overnight at 4°C. On the third day, the slides are once more washed in PBS and the sections are incubated with peroxidase-antiperoxidase (PAP) complex for one hour at 37°C. Alternatively, some sections are incubated in successive steps with antiperoxidase antibody followed by peroxidase enzyme, each for 40 minutes. The slides are washed in PBS and are placed in a PBS solution of 12.5% diaminobenzidine tetrahydrochloride (DAB) and 0.03% H,O, for 15 minutes. The sections are then washed, osmicated, washed, dehydrated and mounted in permount. See Table 1 for a list of antisera used and their characteristics.
Analyses
Since the monoaminergic neurons form long tract systems, it was advantageous to evaluate possible areas of interaction between these neurotransmitters and opioid peptides C(3-END/o-MSH neurons also have long tract projections) in brains that were cut in the sagittal plane. The thickness of the sections varied from animal to animal and was in the range of 10-20 pm. In each animal the right side of the brain was examined. Serial parasagittal sections were ob-
In these panels the common distribution of tyrosine hydroxylase (TH), leu-ENK (LE), 5HT, and cu-MSH (also represents P-END) immunoreactive fibers are demonstrated in serial parasagittal sections (A through D) through the lateral septum (see Fig. 1 for orientation). Note the fine 5HT innervation of the ependyma. V (third ventricle). Bar=50 pm.
tamed and every 10th section was stained with a Nissl stain for orientation purposes. The subsequent sections were stained immunocytochemically with antisera against the following substances (Table 1) : P-END, a-MSH, leu-ENK, serotonin (5HT), tyrosine hydroxylase, and dopamine-/!Ihydroxylase. Observations and photographic analyses were made using a Leitz Orthoplan microscope equipped with an automatic camera system.
RESULTS AND DISCUSSION
Since data presented in this section are in the form of high-power photomicrographs through several regions of the brain in parasagittal sections, the reader is referred to Fig. 1 for a brief introduction as well as for orientation in the subsequent figures.
Norepinephrine-Opioid Peptide Inteructions
The results of this study confirm and further extend the evidence for an extensive interaction between the noradrenergic and opioid peptide systems (references below). Many brain areas that contain opioid peptides are also rich in tyrosine hydroxylase and dopamine-P-hydroxylase immunoreactivities (these enzymes are responsible for the synthesis of DA and NE). This is especially true in the case of @-END/a-MSH projections which appear to coincide with NE projections. Thus, /3-END/a-MSH fibers and terminals were noted in many brain loci rich in NE, such as anterior hypothalamic and preoptic areas (particularly the medial forebrain bundle), dorsomedial nucleus of the hypothalamus, septal nuclei (Fig. 2) , nucleus accumbens, periventricular nucleus of thalamus (Fig. 3) , periaqueductal gray (Fig. 4) . several raphe nuclei (Figs. 13, 14) as well as other noradrenergic cell groups including the locus coeruleus (Figs. 5,  6 ). fnterestingiy, we have noted many P-END/cl-MSH immunoreactive fibers in both the "dorsal and ventral noradrenergic bundles" (Fig. 7) , giving the impression that these peptidergic fibers follow the classical monoamine pathways in a retrograde fashion. Additionally, (w-MSH (from a separate cu-MSH neuronal system which does not contain @-END; [144, 145] ) fibers were also detected in the cortex and hippocampus, reaching these sites via the monoaminerich cingulum bundle. Furthermore, many of the areas mentioned above also contained leu-ENK immunoreactive fibers and terminals (Figs. 2-7, 13, 14) .
Similarly, other investigators, who have mapped the endorphins and enkeph~i~s, have noticed the anatomical proximity of these peptides to the ascending NE fibers (cf. [ 15 11).
A potenti~ for an extensive contact between &END system of fibers and those of the locus coeruleus system was noted by Watson et analgesia is partially antagonized by naloxone f4f. Akil and Liebeskind [2] were able to demonstrate a reciprocal relationship between NE mechanisms and stimulation-produced analgesia thought to involve endogenous opioid systems (i.e., depression of NE activity potentiated the analgesia). Segal and Sandberg 11301 have also been able to elicit stimulation-produced analgesia from sites in the locus coeruleus and substantia nigra. In agreement with this reciprocal relationship [2] and the reciprocal innervation of locus coeruleus and arcuate nucleus alluded to above [ 1511, is the observation that stimulation of the arcuate nucleus resulted in the inhibition of locus coeruleus firing, which was also reversible by naloxone [133] . Thus, the P-END system is apparently inhibitory to the locus coeruleus-noradrenergic system, although it is not as yet clear whether NE is also inhibitory to arcuate @END neurons. Watson ef al. [146] , have implicated the dorsal pe~vent~cular NE bundle as a possible major neuroanatomic substrate for stimulation-produced analgesia. These investigators further noted that the production of analgesia was correlated with the proximity of the stimulating electrode to this NE-containing bundle. Thus, it is apparent that the locus coeruleus-noradrenergic system is involved in the production of analgesia, be it stimulationproduced or morphine-induced.
Furthermore, an interaction between this system and the P-END projection system in the region of the periaqueductal gray is a strong possibility.
Other areas of possible interaction between an opioid peptide and ascending NE systems are the hypothalamic magnocellular nuclei. These nuclei, the supraoptic and paraventricular, are the sites of synthesis of vasopressin and oxytocin (cf. 128,301 . These results, when taken in light of the existence of DYN in vasopressin neurons, would suggest a possible site of interaction between NE and DYN. As interesting a possibility as this seems to be, it should be pointed out that further work remains to be done before one can speculate on possible implications of such interactions.
~~pa~ine-Upi~id Peptide I~teract~u~s
In addition to /3-END/U-MSH projections to noradrenergic cell groups already mentioned, we have also noted /3-END/a-MSH immunoreactive fibers in the vicinity of substantia nigra as well as ventral tegmental dopaminergic nucleus. However, these are scattered fibers and it is not as yet clear whether they innervate these nuclei, or rather are a part of, and represent more ventrally situated p-END/or-MSH fibers which project to the brain stem (pons and medulla). In addition, many leu-ENK immunoreactive fibers were seen within the substantia nigra (Fig. 8) as well as along the nigrostriatal projections to the caudate-put~en (Fig. 9) . Both leu-ENK and tyrosine hydroxylase immunoreactivities were p~icularly heavy in the globus pallidus (Fig. 10) . Other DA-containing cell groups such as the Al2 within the arcuate nucleus (Fig. 11 ) and the Al3 within the zona incerta also contained both leu-ENK and P-END/a?-MSH fibers and terminals. We have also noted the existence of tyrosine hydroxylase and leu-ENK immunoreactivities in the external zone of the median eminence, surrounding the portal capillaries (Fig. 11) . Lastly, in the pituitary, tyrosine hydroxylase-immunoreactive terminals were seen in the intermediate and posterior lobes, but not the anterior lobe (all intermediate lobe cells produce P-END and (w-MSH) (Fig. 12) .
The behavioral effects of the endorphins and enkephalins has led many investigators to suggest that at least some of the actions of these peptides may be mediated through dopaminergic systems, such as catalepsy Bar (panels A and B)= 100 pm. Bar (panels C, D, and inset)=50 pm.
aration of striatum from substantia nigra by hemisections does not alter the striatal met-ENK levels, but that kainic acid induced lesions of the striatum does result in a marked depletion of caudate met-ENK levels [52] . It has also been suggested that at least some, but probably not all ENKbinding sites within the striatum are located on presynaptic DA terminals, since substantia nigra lesions in rats reduced the numbers of 3H-leu-ENK binding sites in the corpus striatum [115] . The latter study, however, did not separate the caudate-putamen from the globus pallidus, site of the highest ENK levels in the brain. Soon thereafter, a striatopallidal leu-ENK pathway was shown to exist in the rat by Cue110 and Paxions [25] in lesion studies that separated the caudate-putamen from the globus pallidus.
Immunocytochemical studies have shown both ENKperikarya [48] and tyrosine hydroxylase axon terminals [ 1141 in the rat neostriatum.
In a recent ultrastructural study. Pickel et al. [113] have demonstrated that the majority of tyrosine hydroxylase-labeled (i.e., DA) axon terminals within the rat neostriatum lack synaptic specializations. They did, however, observe a few axo-dendritic (but no axo-axonic) synapses, arguing that DA axons could exert some effect on the ENK neurons via such axo-dendritic junctions. Therefore, it seems likely that DA might exert a modulatory influence on striatal ENK neurons.
Enkephalins are also present in the substantia nigra as revealed by both radioimmunoassay Parenteral administration of morphine resulted in an increase in the spontaneous firing rate of substantia nigra neurons [58, 70, 71, 1021, but induced the suppression of neurons in the caudate nucleus [70, 71] . The latter investigators noted that morphine might be stimulatory to substantia nigra-DA neurons which in turn innervate the caudate nucleus. In support of these experiments, an increase in DA-fluorescence intensity was demonstrated in the rat and mouse substantia nigra after morphine administration
[46].
Thus narcotic analgesics (i.e., morphine and perhaps other opioid peptides) may exert an inhibitory effect at DA termination areas which would result in sedation and catalepsy [57] , and an excitatory influence on the DA neuronal perikarya which might be due in turn to a presynaptic inhibition of an inhibitory neuronal influence upon those same DA perikarya [29] . It is becoming increasingly clear that P-END and the enkephalins may play a neurotransmitter or neuromodulatory role in conjunction with the catecholamines in many brain areas (cf. and the ventral tegmental area, since motor activity was enhanced following the injection of opiates into these areas [21, 109] . Furthermore, both P-END and met-ENK seem to influence the tuberoinfundibular DA system, since they were stimulatory to growth hormone and prolactin secretion [31, 33, 42, 76, 1181.
Serotonin (SHT)-Opioid Peptide Interactions
In the case of 5HT, we have also noted many central nervous system loci of possible interaction of this monoamine with the opioid peptides. We have already mentioned the brain stem projections of the P-END/o-MSH neuronal system, particularly those to noradrenergic and serotonergic raphe nuclei. We have noted /%END/ol-MSH fibers and terminals within the nucleus raphe dorsalis situated in and adjacent to periaqueductal gray (Fig. 13 ). Many leu-ENK immunoreactive fibers were also seen in the raphe dorsalis (Fig. 13) . Of the other serotonergic nuclei examined that are innervated by both /I-END/a-MSH as well as leu-ENK fibers and terminals, we should also mention the nucleus raphe magnus (Fig. 14) , raphe medianus (nucleus centralis superior), and raphe pontis. Of the several serotonergic pathways examined, one of the most striking in terms of a possible interaction with an opioid peptide, is the serotonergic projection to the dorsal horn of the spinal cord. Serial section examination revealed the existence of dense leu-ENK immunoreactivity occupying the same position in the dorsal horn as the SHT terminals (Fig. 15) .
It seems likely that a 5HT stimulatory mechanism might be involved in the release of pituitary ACTH and P-END. perhaps via corticotropin releasing factor. In support of this notion is the evidence that various stressful stimuli that can enhance brain 5HT turnover [ 100, 137] can also increase the release of ACTH and /?-END [99, 121] . gic stimulatory influence over the basal, and in part, the stress-induced release of pituitary P-END in the rat.
Serotonergic systems may also play an important role in brain mechanisms of pain and analgesia [91] . Experimental manipulations, pharmacological or otherwise, that elevate brain 5HT levels, also produce analgesia in both animals and man [54,63, 85,92, 120, 122, 1231, while those manipulations which reduce SHT levels induce hyperalgesia reversible by 5HT precursors [34, 85] .
It has been shown that the electrical stimulation of some brain regions such as the mesencephalic periaqueductal gray in the vicinity of the nucleus raphe dorsalis results in the production of analgesia (cf. [87] ). In the rat, pretreatment with p-chlorophenylalanine (a 5HT synthesis inhibitor) appears to diminish the tail-flick latency normally caused by periaqueductal gray stimulation [3] . Furthermore, a reversal of this latter effect (of p-chlorophenylalanine) was shown to occur with the administration of 5-hydroxytryptophan, in itself a potentiator of electrical stimulation-produced analgesia [2] . Thus, the possibility exists for an involvement of a serotonergic neuronal system in the mechanism of stimulation-produced analgesia, at least in the periaqueductal gray. Accordingly, experimental evidence points to a positive correlation between high levels of brain 5HT and increased anti-nociception following narcotic administration (cf. [20]).
As was alluded to above, stimulation of periaqueductal gray results in an inhibition of pain transmission through the spinal cord, thus producing analgesia [l, 88, 1031. The nucleus raphe magnus seems to be involved in this mechanism of analgesia produced by the stimulation of periaqueductal gray [35] . The activity of raphe magnus neurons can be al-tered by periaqueductal gray stimulation [I 173. Furthermore, cells of the lamina I and V of the spinal cord (involved in pain transmission) can be inhibited by the stimulation of raphe magnus [35] . However, it should be pointed out that this 5HT system is only a part of a rather complex descending inhibitory system involved in the stimulation-produced or morphine-induced analgesia, including the nucleus reticularis paragigantocellularis
[ 1351, and encompassing several neurotransmitter substances, such as acetylcholine, NE, substance P, and ENK [SO,lOS] .
The nucleus raphe dorsalis is another 5HT nucleus involved in the mechanism of analgesia which can be induced by electrical stimulation or by opiates [lo, 87, 1041. It has been shown that stimulation of raphe dorsalis can potentiate morphine-induced analgesia by increasing forebrain 5HT levels [123] . On the other hand, raphe dorsalis lesions have the opposite effect on morphine analgesia [156] . In the cat, the raphe dorsalis appears to be even more effective a site than periaqueductal gray for stimulation-produced analgesia [104] . Recently, Moss et al. [95] have demonstrated ENK immunoreactive perikarya in the cat raphe dorsalis, thus arguing that the effectiveness of electrical stimulation of the cat raphe dorsalis might be due to the excitation of both ENK-containing and 5HT neurons. In the rat also, ENKperikarya have been shown to exist in the raphe dorsalis [ 1411, but it appears that there are considerably fewer ENK neurons in the rat, especially along the midline [95] . Just how raphe dorsalis fits into the overall pain pathway system, particularly the descending system involving raphe magnus, is not yet well understood. Moreover, through its projections to the limbic structures, raphe dorsalis may be involved in the affective side of pain perception.
CONCLUSIONS
It is now clear that there exists the possibility of an ex-KHACHATURIAN AND WATSON tensive and intimate interaction between the endogenous opioid peptides and the classical monoamine neurotransmitters. Although we can only talk about the possibility of such an interaction due to the limitations of light microscopic immunocytochemistry, still there exist in many cases an unmistakable anatomical proximity between these peptidergic systems and the monoaminergic nuclei and projections. Electron microscopic analyses utilizing both pre-and postsynaptic markers will no doubt provide answers to some of the crucial questions regarding the synaptic or otherwise synaptoid connectivity between such systems.
It is becoming increasingly apparent that the opioid peptides play a neurotransmitter or neuromodulatory role in many brain regions. It is equally apparent that at least a part of this role is played in conjunction with the monoamines. Particularly, the profound behavioral effects of the opioid peptides are a good indication that some of their pharmacological actions must be mediated through the monoamines (i.e., catalepsy, analgesia, neuroendocrine effects).
Further combined pharmacological-morphological studies using manipulative techniques whereby one can alter the pharmacology of one or the other system, could prove valuable in assessing the more subtle influences and interactions of the opioids upon the monoamines and vice versa. Skett. Effects of methionine-enkephalin on prolactin release and catecholamine levels and turnover in the median eminence. 
